The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.
Molecular mechanisms and therapeutic targets for diabetic kidney disease
Open accessAbstract
Diabetic kidney disease has a high global disease burden and substantially increases the risk of kidney failure and cardiovascular events. Despite treatment, there is substantial residual risk of disease progression with existing therapies. Therefore, there is an urgent need to better understand the molecular mechanisms driving diabetic kidney disease to help identify new therapies that slow progression and reduce associated risks. Diabetic kidney disease is initiated by diabetes-related disturbances in glucose metabolism, which then trigger other metabolic, hemodynamic, inflammatory, and fibrotic processes that contribute to disease progression. This review summarizes existing evidence on the molecular drivers of diabetic kidney disease onset and progression, focusing on inflammatory and fibrotic mediators-factors that are largely unaddressed as primary treatment targets and for which there is increasing evidence supporting key roles in the pathophysiology of diabetic kidney disease. Results from recent clinical trials highlight promising new drug therapies, as well as a role for dietary strategies, in treating diabetic kidney disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bikbov, B., Purcell, C. A., Levey, A. S., Smith, M., Abdoli, A., Abebe, M., Adebayo, O. M., Afarideh, M., Agarwal, S. K., Agudelo-Botero, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30045-3 · Cited by 6,648
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Perkovic, V., Jardine, M. J., Neal, B., Bompoint, S., Heerspink, H. J. L., Charytan, D. M., Edwards, R., Agarwal, R., Bakris, G., Bull, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811744 · Cited by 6,189
Self-citationDapagliflozin in Patients with Chronic Kidney Disease
Heerspink, H. J. L., Stefánsson, B. V., Correa-Rotter, R., Chertow, G. M., Greene, T., Hou, F.-F., Mann, J. F. E., McMurray, J. J. V., Lindberg, M., Rossing, P., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2024816 · Cited by 5,618
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2032183 · Cited by 5,205
Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes
Bakris, G. L., Agarwal, R., Anker, S. D., Pitt, B., Ruilope, L. M., Rossing, P., Kolkhof, P., Nowack, C., Schloemer, P., Joseph, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2025845 · Cited by 2,935
Self-citationDiabetic Kidney Disease: Challenges, Progress, and Possibilities
Alicic, R. Z., Rooney, M. T., & Tuttle, K. R. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11491116 · Cited by 2,898
Self-citationA small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Coll, R. C., Robertson, A. A. B., Chae, J. J., Higgins, S. C., Muñoz-Planillo, R., Inserra, M. C., Vetter, I., Dungan, L. S., Monks, B. G., Stutz, A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3806 · Cited by 2,849
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease
Youm, Y.-H., Nguyen, K. Y., Grant, R. W., Goldberg, E. L., Bodogai, M., Kim, D., D'Agostino, D., Planavsky, N., Lupfer, C., Kanneganti, T. D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3804 · Cited by 2,172
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
Frías, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., Liu, B., Cui, X., & Brown, K. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2107519 · Cited by 2,096
Cardiovascular events with finerenone in kidney disease and type 2 diabetes
Pitt, B., Filippatos, G., Agarwal, R., Anker, S. D., Bakris, G. L., Rossing, P., Joseph, A., Kolkhof, P., Nowack, C., Schloemer, P., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2110956 · Cited by 1,814
Self-citationGenetics of diabetes mellitus and diabetes complications
Cole, J. B., & Florez, J. C. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0278-5 · Cited by 1,797
Sattar, N., Lee, M. M. Y., Kristensen, S. L., Branch, K. R. H., Del Prato, S., Khurmi, N. S., Lam, C. S. P., Lopes, R. D., McMurray, J. J. V., Pratley, R. E., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00203-5 · Cited by 1,599
Davies, M., Færch, L., Jeppesen, O. K., Pakseresht, A., Pedersen, S. D., Perreault, L., Rosenstock, J., Shimomura, I., Viljoen, A., Wadden, T. A., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00213-0 · Cited by 1,419
KDIGO 2020 Clinical practice guideline for diabetes management in chronic kidney disease
de Boer, I. H., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.06.019 · Cited by 1,399
Self-citationHeerspink, H. J. L., Perkins, B. A., Fitchett, D. H., Husain, M., & Cherney, D. Z. I. (2016) · Circulation · doi:10.1161/circulationaha.116.021887 · Cited by 1,376
Agarwal, R., Filippatos, G., Pitt, B., Anker, S. D., Rossing, P., Joseph, A., Kolkhof, P., Nowack, C., Gebel, M., Ruilope, L. M., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab777 · Cited by 1,317
Self-citationReichardt, N., Duncan, S. H., Young, P., Belenguer, A., McWilliam Leitch, C., Scott, K. P., Flint, H. J., & Louis, P. (2014) · The ISME Journal · doi:10.1038/ismej.2014.14 · Cited by 1,289
Advanced glycation end products in foods and a practical guide to their reduction in the diet
Uribarri, J., Woodruff, S., Goodman, S., Cai, W., Chen, X., Pyzik, R., Yong, A., Striker, G. E., & Vlassara, H. (2010) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2010.03.018 · Cited by 1,289
Self-citationJager, K. J., Kovesdy, C., Langham, R., Rosenberg, M., Jha, V., & Zoccali, C. (2019) · Kidney International · doi:10.1016/j.kint.2019.07.012 · Cited by 957
Molecular mechanisms of diabetic kidney disease
Reidy, K., Kang, H. M., Hostetter, T., & Susztak, K. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72271 · Cited by 909
Neuen, B. L., Young, T., Heerspink, H. J. L., Neal, B., Perkovic, V., Billot, L., Mahaffey, K. W., Charytan, D. M., Wheeler, D. C., Arnott, C., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30256-6 · Cited by 893
The Gut Microbiome, Kidney Disease, and Targeted Interventions
Ramezani, A., & Raj, D. S. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013080905 · Cited by 743
Tuttle, K. R., Lakshmanan, M. C., Rayner, B., Busch, R. S., Zimmermann, A. G., Woodward, D. B., & Botros, F. T. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30104-9 · Cited by 648
Self-citationType of vegetarian diet, body weight, and prevalence of type 2 diabetes
Tonstad, S., Butler, T., Yan, R., & Fraser, G. E. (2009) · Diabetes Care · doi:10.2337/dc08-1886 · Cited by 641
Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine
Agarwal, R., Kolkhof, P., Bakris, G., Bauersachs, J., Haller, H., Wada, T., & Zannad, F. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa736 · Cited by 638
Self-citationHeerspink, H. J. L., Parving, H.-H., Andress, D. L., Bakris, G., Correa-Rotter, R., Hou, F.-F., Kitzman, D. W., Kohan, D., Makino, H., McMurray, J. J. V., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30772-x · Cited by 628
Self-citationEpigenetics and epigenomics in diabetic kidney disease and metabolic memory
Kato, M., & Natarajan, R. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0135-6 · Cited by 600
Advanced Glycation End Products (AGE) and Diabetes: Cause, Effect, or Both?
Vlassara, H., & Uribarri, J. (2014) · Current Diabetes Reports · doi:10.1007/s11892-013-0453-1 · Cited by 594
Self-citationJannasch, F., Kröger, J., & Schulze, M. B. (2017) · The Journal of Nutrition · doi:10.3945/jn.116.242552 · Cited by 498
Avosentan for Overt Diabetic Nephropathy
Mann, J. F. E., Green, D., Jamerson, K., Ruilope, L. M., Kuranoff, S. J., Littke, T., & Viberti, G. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009060593 · Cited by 492
Vallon, V., Gerasimova, M., Rose, M. A., Masuda, T., Satriano, J., Mayoux, E., Koepsell, H., Thomson, S. C., & Rieg, T. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00520.2013 · Cited by 483
Dietary and nutritional approaches for prevention and management of type 2 diabetes
Forouhi, N. G., Misra, A., Mohan, V., Taylor, R., & Yancy, W. (2018) · BMJ · doi:10.1136/bmj.k2234 · Cited by 472
Diet and exercise in the prevention and treatment of type 2 diabetes mellitus
Magkos, F., Hjorth, M. F., & Astrup, A. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0381-5 · Cited by 469
The tubular hypothesis of nephron filtration and diabetic kidney disease
Vallon, V., & Thomson, S. C. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0256-y · Cited by 465
Heerspink, H. J. L., Perco, P., Mulder, S., Leierer, J., Hansen, M. K., Heinzel, A., & Mayer, G. (2019) · Diabetologia · doi:10.1007/s00125-019-4859-4 · Cited by 457
Niewczas, M. A., Pavkov, M. E., Skupien, J., Smiles, A., Md Dom, Z. I., Wilson, J. M., Park, J., Nair, V., Schlafly, A., Saulnier, P.-J., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0415-5 · Cited by 432
The incidence and implications of aldosterone breakthrough
Bomback, A. S., & Klemmer, P. J. (2007) · Nature Clinical Practice Nephrology · doi:10.1038/ncpneph0575 · Cited by 420
Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy
Shahzad, K., Bock, F., Dong, W., Wang, H., Kopf, S., Kohli, S., Al-Dabet, M. M., Ranjan, S., Wolter, J., Wacker, C., et al. (2015) · Kidney International · doi:10.1038/ki.2014.271 · Cited by 411
Tomita, I., Kume, S., Sugahara, S., Osawa, N., Yamahara, K., Yasuda-Yamahara, M., Takeda, N., Chin-Kanasaki, M., Kaneko, T., Mayoux, E., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.06.020 · Cited by 376
Vallon, V., Rose, M., Gerasimova, M., Satriano, J., Platt, K. A., Koepsell, H., Cunard, R., Sharma, K., Thomson, S. C., & Rieg, T. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00409.2012 · Cited by 370
Dietary Advanced Glycation End Products and Their Role in Health and Disease
Uribarri, J., del Castillo, M. D., de la Maza, M. P., Filip, R., Gugliucci, A., Luevano-Contreras, C., Macías-Cervantes, M. H., Markowicz Bastos, D. H., Medrano, A., Menini, T., et al. (2015) · Advances in Nutrition · doi:10.3945/an.115.008433 · Cited by 369
Self-citationThe Effects of High-Protein Diets on Kidney Health and Longevity
Ko, G.-J., Rhee, C. M., Kalantar-Zadeh, K., & Joshi, S. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020010028 · Cited by 345
11. Chronic Kidney Disease and Risk Management: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s011 · Cited by 344
Wada, T., Furuichi, K., Sakai, N., Iwata, Y., Yoshimoto, K., Shimizu, M., Takeda, S.-I., Takasawa, K., Yoshimura, M., Kida, H., et al. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00311.x · Cited by 341
The Role of Acute Kidney Injury in Chronic Kidney Disease
Hsu, R. K., & Hsu, C.-Y. (2016) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2016.05.005 · Cited by 340
Martín-Peláez, S., Fito, M., & Castaner, O. (2020) · Nutrients · doi:10.3390/nu12082236 · Cited by 330
A plant-based diet for the prevention and treatment of type 2 diabetes.
(2017) · Europe PMC (PubMed Central) · doi:10.11909/j.issn.1671-5411.2017.05.009 · Cited by 320
Berthier, C. C., Zhang, H., Schin, M., Henger, A., Nelson, R. G., Yee, B., Boucherot, A., Neusser, M. A., Cohen, C. D., Carter-Su, C., et al. (2009) · Diabetes · doi:10.2337/db08-1328 · Cited by 317
Self-citationInflammation in Diabetic Kidney Disease
Pérez-Morales, R. E., del Pino, M. D., Valdivielso, J. M., Ortiz, A., Mora-Fernández, C., & Navarro-González, J. F. (2019) · Nephron · doi:10.1159/000493278 · Cited by 304
JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
Fragoulis, G. E., McInnes, I. B., & Siebert, S. (2019) · Rheumatology · doi:10.1093/rheumatology/key276 · Cited by 296
Pichler, R., Afkarian, M., Dieter, B. P., & Tuttle, K. R. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00314.2016 · Cited by 295
Self-citationGrune, J., Beyhoff, N., Smeir, E., Chudek, R., Blumrich, A., Ban, Z., Brix, S., Betz, I. R., Schupp, M., Foryst-Ludwig, A., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.10360 · Cited by 292
Self-citationTuttle, K. R., Brosius, F. C., Adler, S. G., Kretzler, M., Mehta, R. L., Tumlin, J. A., Tanaka, Y., Haneda, M., Liu, J., Silk, M. E., et al. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx377 · Cited by 284
Self-citationKidokoro, K., Cherney, D. Z. I., Bozovic, A., Nagasu, H., Satoh, M., Kanda, E., Sasaki, T., & Kashihara, N. (2019) · Circulation · doi:10.1161/circulationaha.118.037418 · Cited by 283
APOL1 Nephropathy: From Genetics to Clinical Applications
Friedman, D. J., & Pollak, M. R. (2021) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.15161219 · Cited by 270
Loss of the Endothelial Glycocalyx Links Albuminuria and Vascular Dysfunction
Salmon, A. H. J., Ferguson, J. K., Burford, J. L., Gevorgyan, H., Nakano, D., Harper, S. J., Bates, D. O., & Peti-Peterdi, J. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012010017 · Cited by 267
Effects of the SGLT-2 inhibitor dapagliflozin on glomerular and tubular injury markers
Dekkers, C. C. J., Petrykiv, S., Laverman, G. D., Cherney, D. Z., Gansevoort, R. T., & Heerspink, H. J. L. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13301 · Cited by 263
Hyperkalemia risk with finerenone: results from the FIDELIO-DKD Trial
Agarwal, R., Joseph, A., Anker, S. D., Filippatos, G., Rossing, P., Ruilope, L. M., Pitt, B., Kolkhof, P., Scott, C., Lawatscheck, R., et al. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021070942 · Cited by 262
Self-citationTofte, N., Lindhardt, M., Adamova, K., Bakker, S. J. L., Beige, J., Beulens, J. W. J., Birkenfeld, A. L., Currie, G., Delles, C., Dimos, I., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30026-7 · Cited by 262
Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis
Barrera-Chimal, J., Girerd, S., & Jaisser, F. (2019) · Kidney International · doi:10.1016/j.kint.2019.02.030 · Cited by 261
Aldosterone and Vascular Inflammation
Brown, N. J. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.095489 · Cited by 256
Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo
Brown, N. J., Nakamura, S., Ma, L., Nakamura, I., Donnert, E., Freeman, M., Vaughan, D. E., & Fogo, A. B. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00277.x · Cited by 255
Barrera-Chimal, J., Lima-Posada, I., Bakris, G. L., & Jaisser, F. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00490-8 · Cited by 252
Self-citationSchjoedt, K. J., Andersen, S., Rossing, P., Tarnow, L., & Parving, H.-H. (2004) · Diabetologia · doi:10.1007/s00125-004-1542-0 · Cited by 249
Long-term benefits of intensive glucose control for preventing end-stage kidney disease: ADVANCE-ON
Wong, M. G., Perkovic, V., Chalmers, J., Woodward, M., Li, Q., Cooper, M. E., Hamet, P., Harrap, S., Heller, S., MacMahon, S., et al. (2016) · Diabetes Care · doi:10.2337/dc15-2322 · Cited by 240
Vaidya, V. S., Niewczas, M. A., Ficociello, L. H., Johnson, A. C., Collings, F. B., Warram, J. H., Krolewski, A. S., & Bonventre, J. V. (2011) · Kidney International · doi:10.1038/ki.2010.404 · Cited by 234
Ito, S., Kashihara, N., Shikata, K., Nangaku, M., Wada, T., Okuda, Y., & Sawanobori, T. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06870520 · Cited by 234
Snelson, M., & Coughlan, M. (2019) · Nutrients · doi:10.3390/nu11020215 · Cited by 230
Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney Disease
Matoba, K., Takeda, Y., Nagai, Y., Kawanami, D., Utsunomiya, K., & Nishimura, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143393 · Cited by 223
Ojima, A., Matsui, T., Nishino, Y., Nakamura, N., & Yamagishi, S. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0034-1395609 · Cited by 223
Tuttle, K. R., Bruton, J. L., Perusek, M. C., Lancaster, J. L., Kopp, D. T., & DeFronzo, R. A. (1991) · New England Journal of Medicine · doi:10.1056/nejm199106063242304 · Cited by 217
Self-citationMiyata, K., Rahman, M., Shokoji, T., Nagai, Y., Zhang, G.-X., Sun, G.-P., Kimura, S., Yukimura, T., Kiyomoto, H., Kohno, M., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005040390 · Cited by 212
Salem, R. M., Todd, J. N., Sandholm, N., Cole, J. B., Chen, W.-M., Andrews, D., Pezzolesi, M. G., McKeigue, P. M., Hiraki, L. T., Qiu, C., et al. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019030218 · Cited by 206
A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes
van Zuydam, N. R., Ahlqvist, E., Sandholm, N., Deshmukh, H., Rayner, N. W., Abdalla, M., Ladenvall, C., Ziemek, D., Fauman, E., Robertson, N. R., et al. (2018) · Diabetes · doi:10.2337/db17-0914 · Cited by 195
Diabetic kidney disease: from physiology to therapeutics
Mora‐Fernández, C., Domínguez‐Pimentel, V., de Fuentes, M. M., Górriz, J. L., Martínez‐Castelao, A., & Navarro‐González, J. F. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.272328 · Cited by 194
Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence
Alicic, R. Z., Cox, E. J., Neumiller, J. J., & Tuttle, K. R. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00367-2 · Cited by 193
Self-citationRangaswami, J., Bhalla, V., de Boer, I. H., Staruschenko, A., Sharp, J. A., Singh, R. R., Lo, K. B., Tuttle, K., Vaduganathan, M., Ventura, H., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000920 · Cited by 192
Self-citationRenal Inflammation and Fibrosis: A Double-edged Sword
Black, L. M., Lever, J. M., & Agarwal, A. (2019) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155419852932 · Cited by 192
Barrera-Chimal, J., Estrela, G. R., Lechner, S. M., Giraud, S., El Moghrabi, S., Kaaki, S., Kolkhof, P., Hauet, T., & Jaisser, F. (2018) · Kidney International · doi:10.1016/j.kint.2017.12.016 · Cited by 183
Self-citationBrown, N. J., Kim, K.-S., Chen, Y.-Q., Blevins, L. S., Nadeau, J. H., Meranze, S. G., & Vaughan, D. E. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6305 · Cited by 182
Kolkhof, P., Jaisser, F., Kim, S.-Y., Filippatos, G., Nowack, C., & Pitt, B. (2016) · Handbook of Experimental Pharmacology · doi:10.1007/164_2016_76 · Cited by 180
Self-citationThe glycocalyx—linking albuminuria with renal and cardiovascular disease
Rabelink, T. J., & de Zeeuw, D. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.162 · Cited by 178
Acute Kidney Injury and Progression of Diabetic Kidney Disease
Yu, S. M.-W., & Bonventre, J. V. (2018) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2017.12.005 · Cited by 175
Rossing, P. R., Filippatos, G. S., Agarwal, R., Anker, S. D., Pitt, B., Ruilope, L. M., Chan, J. C. N., Kooy, A., McCafferty, K., Schernthaner, G., et al. (2021) · Kidney International Reports · doi:10.1016/j.ekir.2021.10.008 · Cited by 168
Self-citationProcessed foods drive intestinal barrier permeability and microvascular diseases
Snelson, M., Tan, S. M., Clarke, R., de Pasquale, C., Thallas‐Bonke, V., Nguyen, T.-V., Penfold, S. A., Harcourt, B. E., Sourris, K. C., Lindblom, R. S. J., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe4841 · Cited by 167
The New Biology of Diabetic Kidney Disease—Mechanisms and Therapeutic Implications
Lytvyn, Y., Bjornstad, P., van Raalte, D. H., Heerspink, H. L., & Cherney, D. Z. I. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnz010 · Cited by 165
TLR4 Activation Promotes Podocyte Injury and Interstitial Fibrosis in Diabetic Nephropathy
Ma, J., Chadban, S. J., Zhao, C. Y., Chen, X., Kwan, T., Panchapakesan, U., Pollock, C. A., & Wu, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097985 · Cited by 160
Transforming Growth Factor-Beta1 in Diabetic Kidney Disease
Zhao, L., Zou, Y., & Liu, F. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00187 · Cited by 160
Inflammatory Mechanisms as New Biomarkers and Therapeutic Targets for Diabetic Kidney Disease
Alicic, R. Z., Johnson, E. J., & Tuttle, K. R. (2018) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2017.12.002 · Cited by 159
Self-citationThe key role of NLRP3 and STING in APOL1-associated podocytopathy
Wu, J., Raman, A., Coffey, N. J., Sheng, X., Wahba, J., Seasock, M. J., Ma, Z., Beckerman, P., Laczko, D. I., Palmer, M. B., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci136329 · Cited by 151
ASK1 contributes to fibrosis and dysfunction in models of kidney disease
Liles, J. T., Corkey, B. K., Notte, G. T., Budas, G. R., Lansdon, E. B., Hinojosa-Kirschenbaum, F., Badal, S. S., Lee, M., Schultz, B. E., Wise, S. J., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99768 · Cited by 147
Kolkhof, P., Hartmann, E., Freyberger, A., Pavkovic, M., Mathar, I., Sandner, P., Droebner, K., Joseph, A., Hüser, J., & Eitner, F. (2021) · American Journal of Nephrology · doi:10.1159/000516213 · Cited by 143
Self-citationMacrophage in chronic kidney disease
Guiteras, R., Flaquer, M., & Cruzado, J. M. (2016) · Clinical Kidney Journal · doi:10.1093/ckj/sfw096 · Cited by 141
Yacoub, R., Nugent, M., Cai, W., Nadkarni, G. N., Chaves, L. D., Abyad, S., Honan, A. M., Thomas, S. A., Zheng, W., Valiyaparambil, S. A., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0184789 · Cited by 139
Self-citationBoels, M. G. S., Avramut, M. C., Koudijs, A., Dane, M. J. C., Lee, D. H., van der Vlag, J., Koster, A. J., van Zonneveld, A. J., van Faassen, E. E., Gröne, H., et al. (2016) · Diabetes · doi:10.2337/db15-1413 · Cited by 135
Sodium–Glucose Cotransporter 2 Inhibition and Diabetic Kidney Disease
Alicic, R. Z., Neumiller, J. J., Johnson, E. J., Dieter, B. P., & Tuttle, K. R. (2019) · Diabetes · doi:10.2337/dbi18-0007 · Cited by 134
Self-citationCTGF in kidney fibrosis and glomerulonephritis
Toda, N., Mukoyama, M., Yanagita, M., & Yokoi, H. (2018) · Inflammation and Regeneration · doi:10.1186/s41232-018-0070-0 · Cited by 132
GLP-1 receptor agonists in diabetic kidney disease: from clinical outcomes to mechanisms
Kawanami, D., & Takashi, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00967 · Cited by 129
Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation
Young, M. J. (2008) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3282f56854 · Cited by 125
Potential kidney protection with liraglutide and semaglutide: Exploratory mediation analysis
Mann, J. F. E., Buse, J. B., Idorn, T., Leiter, L. A., Pratley, R. E., Rasmussen, S., Vilsbøll, T., Wolthers, B., & Perkovic, V. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14443 · Cited by 120
NLRP3 Inflammasome Mediates Aldosterone-Induced Vascular Damage
Bruder-Nascimento, T. B., Ferreira, N. S., Zanotto, C. Z., Ramalho, F. N. Z., Pequeno, I. O., Olivon, V. C., Neves, K. B., Alves-Lopes, R., Campos, E., Silva, C. A. A., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.024369 · Cited by 118
Cannon, C. P., Perkovic, V., Agarwal, R., Baldassarre, J., Bakris, G., Charytan, D. M., de Zeeuw, D., Edwards, R., Greene, T., Heerspink, H. J. L., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044359 · Cited by 117
Self-citationThe Role of the Mineralocorticoid Receptor in Inflammation: Focus on Kidney and Vasculature
Belden, Z., Deiuliis, J. A., Dobre, M. A., & Rajagopalan, S. (2017) · American Journal of Nephrology · doi:10.1159/000480652 · Cited by 112
Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial
The EMPA-KIDNEY Collaborative Group, Herrington, W. G., Wanner, C., Green, J. B., Hauske, S. J., Judge, P., Mayne, K. J., Ng, S. Y. A., Sammons, E., Zhu, D., et al. (2022) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfac040 · Cited by 110
Self-citationSystematic integrated analysis of genetic and epigenetic variation in diabetic kidney disease
Sheng, X., Qiu, C., Liu, H., Gluck, C. A., Hsu, J. Y., He, J., Hsu, C., Sha, D., Weir, M. R., Isakova, T., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2005905117 · Cited by 108
Podocyte-specific JAK2 overexpression worsens diabetic kidney disease in mice
Zhang, H., Nair, V., Saha, J., Atkins, K. B., Hodgin, J. B., Saunders, T. L., Myers, M. G., Werner, T. B., Kretzler, M., & Brosius, F. C. (2017) · Kidney International · doi:10.1016/j.kint.2017.03.027 · Cited by 107
Self-citationThe role of the microbiome in diabetes mellitus
Zhang, S., Cai, Y., Meng, C., Ding, X., Huang, J., Luo, X., Cao, Y., Gao, F., & Zou, M. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108645 · Cited by 107
Ramnath, R. D., Butler, M. J., Newman, G., Desideri, S., Russell, A., Lay, A. C., Neal, C., Qiu, Y., Fawaz, S., Onions, K. L., et al. (2019) · Kidney International · doi:10.1016/j.kint.2019.09.035 · Cited by 106
Mosterd, C. M., Kanbay, M., van den Born, B. H., van Raalte, D. H., & Rampanelli, E. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101484 · Cited by 104
Sen, T., Li, J., Neuen, B. L., Neal, B. C., Arnott, C. G., Parikh, C. R., Coca, S. G., Perkovic, V., Mahaffey, K. W., Yavin, Y., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05512-5 · Cited by 100
Effects of Selonsertib in Patients with Diabetic Kidney Disease
Chertow, G. M., Pérgola, P. E., Fang, C., Kirby, B. J., Sundy, J. S., Patel, U. D., & for the GS-US-223-1015 Investigators (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018121231 · Cited by 97
ASK1 Inhibitor Halts Progression of Diabetic Nephropathy in Nos3-Deficient Mice
Tesch, G. H., Ma, F. Y., Han, Y., Liles, J. T., Breckenridge, D. G., & Nikolic‐Paterson, D. J. (2015) · Diabetes · doi:10.2337/db15-0384 · Cited by 95
Baye, E., Kiriakova, V., Uribarri, J., Moran, L., & de Courten, B. V. (2017) · Scientific Reports · doi:10.1038/s41598-017-02268-0 · Cited by 90
Self-citationGalectin-3 is independently associated with progression of nephropathy in type 2 diabetes mellitus
Tan, K. C. B., Cheung, C., Lee, A. C. H., Lam, J. K. Y., Wong, Y., & Shiu, S. W. M. (2018) · Diabetologia · doi:10.1007/s00125-018-4552-z · Cited by 90
Serum amyloid A and inflammation in diabetic kidney disease and podocytes
Anderberg, R. J., Meek, R. L., Hudkins, K. L., Cooney, S. K., Alpers, C. E., LeBoeuf, R. C., & Tuttle, K. R. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.163 · Cited by 87
Self-citationThe role of RAGE in the pathogenesis of intestinal barrier dysfunction after hemorrhagic shock
Raman, K. G., Sappington, P. L., Yang, R., Levy, R. M., Prince, J. M., Liu, S., Watkins, S. C., Schmidt, A. M., Billiar, T. R., & Fink, M. P. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00055.2006 · Cited by 80
Saulnier, P., Gand, E., Ragot, S., Ducrocq, G., Halimi, J., Hulin-Delmotte, C., Llaty, P., Montaigne, D., Rigalleau, V., Roussel, R., et al. (2014) · Diabetes Care · doi:10.2337/dc13-2580 · Cited by 78
van den Berg, B. M., Wang, G., Boels, M. G. S., Avramut, M. C., Jansen, E., Sol, W. M. P. J., Lebrin, F., van Zonneveld, A. J., de Koning, E. J. P., Vink, H., et al. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019020192 · Cited by 76
Kadoya, H., Satoh, M., Sasaki, T., Taniguchi, S., Takahashi, M., & Kashihara, N. (2015) · The FASEB Journal · doi:10.1096/fj.15-271734 · Cited by 74
Mineralocorticoid receptor activation in obesity hypertension
Nagase, M., & Fujita, T. (2009) · Hypertension Research · doi:10.1038/hr.2009.86 · Cited by 72
SGLT2 inhibitors: the future for treatment of type 2 diabetes mellitus and other chronic diseases
Wanner, C., & Marx, N. (2018) · Diabetologia · doi:10.1007/s00125-018-4678-z · Cited by 65
Biglycan, a novel trigger of Th1 and Th17 cell recruitment into the kidney
Nastase, M. V., Zeng-Brouwers, J., Beckmann, J., Tredup, C., Christen, U., Radeke, H. H., Wygrecka, M., & Schaefer, L. (2018) · Matrix Biology · doi:10.1016/j.matbio.2017.12.002 · Cited by 60
Guan, M., Keaton, J. M., Dimitrov, L. M., Hicks, P. J., Xu, J., Palmer, N. D., Ma, L., Das, S. K., Chen, Y.-D. I., Coresh, J., et al. (2019) · Human Genomics · doi:10.1186/s40246-019-0205-7 · Cited by 57
Garay‐Sevilla, M. E., Beeri, M. S., de la Maza, M. P., Armando Rojas, R., Salazar‐Villanea, S., & Uribarri, J. (2020) · Nutrition Research Reviews · doi:10.1017/s0954422420000104 · Cited by 56
Self-citationEffects of amino acids and glucagon on renal hemodynamics in type 1 diabetes
Tuttle, K. R., Puhlman, M. E., Cooney, S. K., & Short, R. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00155.2001 · Cited by 50
Self-citationActivation of endothelial NAD(P)H oxidase accelerates early glomerular injury in diabetic mice
Nagasu, H., Satoh, M., Kiyokage, E., Kidokoro, K., Toida, K., Channon, K. M., Kanwar, Y. S., Sasaki, T., & Kashihara, N. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2015.128 · Cited by 50
Systemic Inflammation Precedes Microalbuminuria in Diabetes
Scurt, F. G., Menne, J., Brandt, S., Bernhardt, A., Mertens, P. R., Haller, H. G., Chatzikyrkou, C., Ito, S., Izzo, J. L., Januszewicz, A., et al. (2019) · Kidney International Reports · doi:10.1016/j.ekir.2019.06.005 · Cited by 48
van Bommel, E. J. M., Lytvyn, Y., Perkins, B. A., Soleymanlou, N., Fagan, N. M., Koitka-Weber, A., Joles, J. A., Cherney, D. Z. I., & van Raalte, D. H. (2020) · Kidney International · doi:10.1016/j.kint.2019.12.021 · Cited by 47
Sakai, N., & Wada, T. (2014) · Kidney International · doi:10.1038/ki.2014.322 · Cited by 46
The Renin-Angiotensin-Aldosterone System and Fibrinolysis in Progressive Renal Disease
Brown, N. J., Vaughan, D. E., & Fogo, A. B. (2002) · Seminars in Nephrology · doi:10.1053/snep.2002.34725 · Cited by 45
Diener, C., Reyes‐Escogido, M. D. L., Jiménez-Ceja, L. M., Matus, M. G., Navarro, C. M. G., Chu, N. D., Zhong, V., Tejero, M. E., Alm, E. J., Reséndis-Antonio, O., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.602326 · Cited by 45
Eleftheriadis, T., Pissas, G., Tsogka, K., Nikolaou, E., Liakopoulos, V., & Stefanidis, I. (2020) · International Urology and Nephrology · doi:10.1007/s11255-020-02481-3 · Cited by 44
SGLT2 inhibitors may offer benefit beyond diabetes
Kang, A., & Jardine, M. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00391-2 · Cited by 43
Tuttle, K. R., & Bruton, J. L. (1992) · Kidney International · doi:10.1038/ki.1992.274 · Cited by 42
Self-citationWang, C., Lee, A., Liu, S., Chang, K., Shen, M., & Chang, C. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1534-4 · Cited by 42
Exendin-4 ameliorates renal ischemia-reperfusion injury in the rat
Yang, H., Li, H., Wang, Z., Shi, Y., Jiang, G., & Zeng, F. (2013) · Journal of Surgical Research · doi:10.1016/j.jss.2013.06.042 · Cited by 34
GLP-1R agonists for the treatment of obesity: a patent review (2015-present)
Liu, C., Zou, Y., & Qian, H. (2020) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2020.1811851 · Cited by 32
Hayashi, T., Shibata, H., Kurihara, I., Yokota, K., Mitsuishi, Y., Ohashi, K., Murai‐Takeda, A., Jo, R., Ohyama, T., Sakamoto, M., et al. (2017) · International Heart Journal · doi:10.1536/ihj.16-649 · Cited by 30
Novel approaches to hypoglycemia and burnt-out diabetes in chronic kidney disease
Rhee, C. M., Kalantar‐Zadeh, K., & Tuttle, K. R. (2021) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000756 · Cited by 27
Self-citationZhang, L., Xue, S., Hou, J., Chen, G., & Xu, Z. (2020) · World Journal of Diabetes · doi:10.4239/wjd.v11.i11.553 · Cited by 26
Adenosine inhibits renin release from juxtaglomerular cells via an A1receptor-TRPC-mediated pathway
Ortiz‐Capisano, M. C., Atchison, D. K., Harding, P., Lasley, R. D., & Beierwaltes, W. H. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00710.2012 · Cited by 22
Juarez, G. M. F., Pérez, J. V., Fernández, J. L. L., Martínez‐Martínez, E., Cachofeiro, V., Lucía, V. B., Ribera, A. M. T., Abreu, Á. M., Cordon, A., Dominguez, J. A. O., et al. (2016) · Nephrology · doi:10.1111/nep.12781 · Cited by 22
Cited by
Ndumele, C. E., Neeland, I. J., Tuttle, K. R., Chow, S. L., Mathew, R. O., Khan, S. S., Coresh, J., Baker-Smith, C. M., Carnethon, M. R., Després, J.-P., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001186 · Cited by 1,405
Self-citationType 2 diabetes mellitus in adults: pathogenesis, prevention and therapy
Lu, X., Xie, Q., Pan, X., Zhang, R., Zhang, X., Peng, G., Zhang, Y., Shen, S., & Tong, N. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01951-9 · Cited by 665
Diabetic Nephropathy: Update on Pillars of Therapy Slowing Progression
Naaman, S. C., & Bakris, G. L. (2023) · Diabetes Care · doi:10.2337/dci23-0030 · Cited by 292
Self-citationMann, J. F. E., Rossing, P., Bakris, G., Belmar, N., Bosch-Traberg, H., Busch, R., Charytan, D. M., Hadjadj, S., Gillard, P., Górriz, J. L., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03133-0 · Cited by 200
“Since the molecular mechanisms of action of both drug classes on the CV system and the kidney may be complementary and largely independent of glucose lowering 6 , it has been speculated that the combination might further improve clinical outcomes.”
BackgroundSelf-citationJha, R., Lopez-Trevino, S., Kankanamalage, H. R., & Jha, J. C. (2024) · Biomedicines · doi:10.3390/biomedicines12051098 · Cited by 144
Metadata
- Authors
- Tuttle, K. R., Agarwal, R., Alpers, C. E., Bakris, G. L., Brosius, F. C., Kolkhof, P., & Uribarri, J.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2022-08
- Volume
- 102
- Issue
- 2
- Pages
- 248-260
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W4281918786
- Cited by
- 668
- References
- 142
- FWCI
- 64.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.